scout
|Videos|October 20, 2017

The Importance of CNS Activity in Agents for NSCLC

Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the importance of central nervous system (CNS) activity in agents for the treatment of non–small cell lung cancer (NSCLC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME